| Literature DB >> 30455845 |
Arturo Forner-Cordero1, Guilherme Silva Umemura1, Fabianne Furtado1,2, Bruno da Silva Brandão Gonçalves3.
Abstract
Sleep quality analysis is crucial for human health and it is related to duration, rhythm and quality. The goal of this study is to analyze objective assessment of the sleep-wake cycles with actigraphy, subjective questionnaires and their relationship with sleep quality indices. A wearable actigraph registered the sleep habits of 41 healthy subjects for 9 days. Afterwards, the subjects filled two questionnaires about sleep quality (Pittsburgh Sleep Quality Index) and sleepiness (Epworth Sleepiness Scale). The subjects were divided into two groups based on cut-off scores and the actigraphy parameters were compared between groups. Group 1 in ESS and PSQI categorization had less diurnal sleepiness and better sleep quality, respectively, than Group 2. Measurements of regularity (IS), fragmentation (IV), active phase amplitude (M10), rest amplitude (L5), and relative amplitude (RA) were compared between groups. Group 2 had higher L5 values. Parameter L5 (lowest of 5 consecutive hours of activity) was concluded to be relevant to identify the sleep conditions of the subjects.Entities:
Keywords: Actigraphy; Sleep Deprivation; Surveys and Questionnaires
Year: 2018 PMID: 30455845 PMCID: PMC6201524 DOI: 10.5935/1984-0063.20180027
Source DB: PubMed Journal: Sleep Sci ISSN: 1984-0063
Figure 1Actogram, raw actigraphy data along with the detection of the sleep intervals
Between group differences in the circadian parameters.
| Circadian Parameters | Questionnaires | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| ESS- Mean (SD) and 95% CI for mean: | Upper | PSQI- Mean (SD) and 95% CI for mean: | Upper | ||||||
| Lower | Lower | ||||||||
| IS | Group1 | .309 | (0.0794) | 0.273 | .321 | (0.0779) | 0.285 | ||
| 0.345 | 0.356 | ||||||||
| Group2 | .343 | (0.1000) | 0.296 | .331 | (0.1040) | 0.282 | |||
| 0.390 | 0.380 | ||||||||
| IV | Group1 | .724 | (0.0939) | 0.682 | .731 | (0.0893) | 0.690 | ||
| 0.767 | 0.771 | ||||||||
| Group2 | .677 | (0.1438) | 0.609 | .670 | (0.1442) | 0.603 | |||
| 0.744 | 0.738 | ||||||||
| M10 | Group1 | 3290422 | (689010) | 2976789 | 3183031 | (615794) | 2902726 | ||
| 3604057 | 3463338 | ||||||||
| Group2 | 3570038 | (1086026) | 3061763 | 3682799 | (1089727) | 3172791 | |||
| 4078315 | 4192807 | ||||||||
| L5 | Group1 | 46617 | (45562) | 25877 | 40144 | (18360) | 31787 | ||
| 67357 | 48502 | ||||||||
| Group2 | 63912 | (51216) | 39942 | 70708 | (64117) | 40701 | |||
| 87883 | 100717 | ||||||||
| Ra | Group1 | .972 | (0.0226) | 0.962 | .974 | (0.0132) | 0.968 | ||
| 0.982 | 0.980 | ||||||||
| Group2 | .963 | (0.0263) | 0.950 | .961 | (0.0318) | 0.946 | |||
| 0.975 | 0.976 | ||||||||
p<0.05 in independent T test.
Figure 2L5 values in PSQI Groups.